Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

Opioids mimic the body's natural pain relievers, binding to receptor proteins in the brain and sometimes inducing euphoria. National Corporate funding for NOVA is provided by Carlisle Companies.